Structure Patients treated with tesamorelin for 52 weeks (T-T group) showed no change between Weeks 26 and 52 in mean trunk fat (increase of 0.1 kg in Study 1 and decrease of 0.5 kg in Study 2, respectively, compared with an increase of 1.4 kg in patients in the T-P group in Study 1 and an increase of 1.09 kg in Study 2, respectively) nor was there a change from Week 26 baseline in mean lean body mass (decrease of 0.1 kg in Study 1 and increase of 0.1 kg in Study 2, respectively, compared with a decrease of 1.8 kg in patients in the T-P group in Study 1 and a decrease of 1.7 kg in Study 2, respectively)
Making an Informed Choice Your health profile and weight loss goals will determine the best choice between GLP-1 medications and ketogenic diets
Peptide protocols change your meal plan should be just as flexible
Patients with diverticular disease should maintain high-fibre intake, adequate hydration and monitor for new or worsening abdominal pain
The goal is consistent daily protein intake spread evenly across meals
doi: 10.1177/2042018814543483 185 FarshchianMAnsarASobhanMHoseinpoorV